Zynerba Pharmaceuticals, Inc.

NasdaqCM:ZYNE Stock Report

Market Cap: US$65.6m

Zynerba Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:ZYNE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Sep 23SellUS$3,321Kenneth JonesIndividual2,505US$1.33
13 Sep 23SellUS$11,929James FickenscherIndividual8,998US$1.33
13 Sep 23SellUS$8,499Brian RosenbergerIndividual6,411US$1.33
13 Sep 23SellUS$16,440Terri SebreeIndividual12,401US$1.33
13 Sep 23SellUS$23,637Armando AnidoIndividual17,830US$1.33
14 Jun 23SellUS$40Warren CooperIndividual115US$0.35
14 Jun 23SellUS$40John ButlerIndividual115US$0.35
14 Jun 23SellUS$40William FedericiIndividual115US$0.35
14 Jun 23SellUS$40Daniel KisnerIndividual115US$0.35
14 Jun 23SellUS$40Kenneth MochIndividual115US$0.35
14 Jun 23SellUS$40Pamela StephensonIndividual115US$0.35

Insider Trading Volume

Insider Buying: ZYNE insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of ZYNE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies15,8170.0313%
Individual Insiders2,972,6945.89%
Hedge Funds4,426,3818.77%
Institutions6,048,39912%
Public Companies7,592,49815%
General Public29,403,21058.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.1%.


Top Shareholders

Top 25 shareholders own 40.62% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.1%
Harmony Biosciences Holdings, Inc.
7,592,498US$9.9m0%no data
8.77%
Beryl Capital Management LLC
4,426,381US$5.8m0%2.6%
4.32%
The Vanguard Group, Inc.
2,179,600US$2.8m0%no data
1.94%
Armando Anido
976,614US$1.3m-20.9%no data
1.47%
BlackRock, Inc.
740,524US$962.7k-11.7%no data
1.43%
ETF Managers Group LLC
723,151US$940.1k0%0.03%
1.37%
Renaissance Technologies LLC
689,713US$896.6k21.1%no data
1.18%
Terri Sebree
596,241US$775.1k-23.4%no data
0.77%
Geode Capital Management, LLC
387,346US$503.6k0%no data
0.75%
James Fickenscher
378,087US$491.5k-32.1%no data
0.49%
Brian Rosenberger
249,559US$324.4k6.75%no data
0.45%
Albert Parker
227,018US$295.1k0%no data
0.44%
Penserra Capital Management LLC
220,858US$287.1k0.78%0.01%
0.25%
Millennium Management LLC
125,835US$163.6k-72.4%no data
0.25%
Two Sigma Advisers, LP
124,000US$161.2k-14.4%no data
0.24%
State Street Global Advisors, Inc.
119,741US$155.7k0%no data
0.23%
Northern Trust Global Investments
115,210US$149.8k0%no data
0.17%
Kenneth Jones
85,520US$111.2k0%no data
0.16%
John Butler
80,765US$105.0k144%no data
0.16%
Bernardo Wealth Planning, LLC
78,578US$102.2k104%0.04%
0.15%
Pamela Stephenson
75,778US$98.5k170%no data
0.15%
Warren Cooper
75,778US$98.5k170%no data
0.15%
Kenneth Moch
75,778US$98.5k170%no data
0.15%
Daniel Kisner
75,778US$98.5k170%no data
0.15%
William Federici
75,778US$98.5k170%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.